We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$7.14B
Cap. Flow %
-1.5%
Top 10 Hldgs %
17.9%
Holding
5,783
New
812
Increased
2,513
Reduced
1,655
Closed
342
Avg Time Held Equity + Options
9.4 quarters
Top 10 Avg Time Held Equity + Options
10 quarters
Top 20 Avg Time Held Equity + Options
9.2 quarters
Avg Time Held Equity only
10.3 quarters
Top 10 Avg Time Held Equity only
10.9 quarters
Top 20 Avg Time Held Equity only
9.3 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.01%
2 Financials 14.82%
3 Technology 12.49%
4 Healthcare 9.61%
5 Consumer Discretionary 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CATM
2401
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$6.17M ﹤0.01%
333,276
-29,376
-8% -$588K
2013 Q2
18 quarters
UTL icon
2402
Unitil
UTL
$938M
$6.17M ﹤0.01%
135,201
-2,053
-1% -$103K
2013 Q2
18 quarters
SGYP
2403
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$6.16M ﹤0.01%
2,763,538
-641,839
-19% -$1.6M
2015 Q2
10 quarters
CRZO
2404
DELISTED
Carrizo Oil & Gas Inc
CRZO
$6.15M ﹤0.01%
289,105
+286,361
+10,436% +$5.29M
2013 Q2
18 quarters
SRCL
2405
DELISTED
Stericycle Inc
SRCL
$6.14M ﹤0.01%
90,278
-58,794
-39% -$3.99M
2013 Q2
18 quarters
SLV icon
2406
iShares Silver Trust
SLV
$29.8B
$6.13M ﹤0.01%
383,662
-141,447
-27% -$2.23M
2013 Q2
18 quarters
AIMT
2407
DELISTED
Aimmune Therapeutics
AIMT
$6.11M ﹤0.01%
161,609
-132,796
-45% -$4.28M
2016 Q1
7 quarters
ESND
2408
DELISTED
Essendant Inc.
ESND
$6.11M ﹤0.01%
659,230
-57,385
-8% -$590K
2013 Q2
18 quarters
FSP
2409
Franklin Street Properties
FSP
$38M
$6.11M ﹤0.01%
568,534
+180,442
+46% +$1.9M
2013 Q2
18 quarters
EGL
2410
DELISTED
Engility Holdings, Inc.
EGL
$6.11M ﹤0.01%
215,163
-3,832
-2% -$117K
2013 Q2
18 quarters
VOOG icon
2411
Vanguard S&P 500 Growth ETF
VOOG
$27.9B
$6.09M ﹤0.01%
266,976
+265,176
+14,732% +$5.93M
2016 Q4
4 quarters
SABR icon
2412
Sabre
SABR
$799M
$6.08M ﹤0.01%
296,499
+231,373
+355% +$4.43M
2014 Q2
14 quarters
AFL icon
2413
PUT
Aflac
AFL
$55.6B
$6.07M ﹤0.01%
138,400
-160,000
-54% -$6.83M
2017 Q3
1 quarter
AN icon
2414
AutoNation
AN
$5.52B
$6.07M ﹤0.01%
118,307
+58,336
+97% +$2.96M
2013 Q2
18 quarters
JSD
2415
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
$6.07M ﹤0.01%
365,119
+6,631
+2% +$113K
2014 Q4
12 quarters
SSB icon
2416
SouthState Bank Corp
SSB
$9.87B
$6.06M ﹤0.01%
69,502
+17,498
+34% +$1.57M
2014 Q3
13 quarters
TER icon
2417
CALL
Teradyne
TER
$68.1B
$6.05M ﹤0.01%
144,600
– –
2017 Q3
1 quarter
VCSH icon
2418
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.1B
$6.05M ﹤0.01%
76,306
+32,049
+72% +$2.55M
2013 Q2
18 quarters
KL
2419
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$6.05M ﹤0.01%
393,836
-20,573
-5% -$283K
2017 Q3
1 quarter
CVGW
2420
DELISTED
Calavo Growers
CVGW
$6.05M ﹤0.01%
71,668
+19,655
+38% +$1.45M
2013 Q2
18 quarters
CHKP icon
2421
Check Point Software Technologies
CHKP
$13.4B
$6.04M ﹤0.01%
58,348
-397,598
-87% -$43.2M
2013 Q2
18 quarters
ACWX icon
2422
iShares MSCI ACWI ex US ETF
ACWX
$16B
$6.04M ﹤0.01%
120,830
-22,881
-16% -$1.13M
2013 Q2
18 quarters
SBCF icon
2423
Seacoast Banking Corp of Florida
SBCF
$3.16B
$6.03M ﹤0.01%
239,065
+40,445
+20% +$1.01M
2016 Q4
4 quarters
LUMN icon
2424
CALL
Lumen
LUMN
$5.93B
$6.03M ﹤0.01%
361,200
-22,800
-6% -$387K
2015 Q4
8 quarters
INVA icon
2425
Innoviva
INVA
$1.49B
$6.01M ﹤0.01%
423,630
-356,916
-46% -$4.76M
2016 Q4
4 quarters

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.